The results showed that JAKis can affect the distribution of B-cell subpopulations and regulate expression of B-cell activation molecules and phosphorylation of key kinases in the BCR signalling pathway and that these changes are associated with disease remission in RA patients. This evidence concerns the gene BCR and rheumatoid arthritis.